Skip to content
Screener

NovoCure NVCR Switzerland — Total long lived assets

Other geography segments

United States
$65.67M
Israel
$14.06M

Similar metrics at other companies

Align Technology logo
ALGNSwitzerland — Total long-lived assets
$197.32M-64.9%
MoonLake Immunotherapeutics logo
MLTXSwitzerland — Long-Lived Assets
$888K+64.7%
Cimpress PLC logo
CMPRSWITZERLAND — Long-Lived Assets
$76.15M+4.4%
Philip Morris International logo
PMSwitzerland: — Long-Lived Assets
$1.7B+21.4%
FMC Corporation logo
FMCSwitzerland — Long-Lived Assets
$1.41B-31.4%
N-able logo
NABLSwitzerland — Total long-lived assets, net
$11.74M-14.6%

Other financials

Income statement

See full
Revenue$183.6M+15.6%
Gross profit$142.5M+21.4%
Operating income-$10.6M+73.3%
Net income-$15.7M+61.0%
EPS (diluted)-$0.13+63.9%

Balance sheet

See full
Cash & equivalents$93.7M-37.4%
Total debt$37.5M-12.4%
Total equity$338.1M-3.2%
Total assets$795.2M-36.2%

Cash flow

See full
Operating cash flow$8.1M+151%
CapEx$6.9M+26.1%
Free cash flow$1.2M+106%

Valuation

See full
Market cap$1.91B+56.6%
Enterprise value$1.85B+66.6%
P/S2.7×+0.8×

Profitability

See full
Gross margin76.1%-0.3pp
Operating margin-22.1%-3.6pp
Net margin-21.2%-3.8pp
FCF margin-3.6%-1.5pp

Returns & leverage

See full
Return on equity-43.2%-4.0pp
Debt / equity0.1×0.0×
Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:NoncurrentAssets.

The source filing: NovoCure’s 10-Q, filed July 23, 2026.

Filed
Jul 23, 2026, 6:59 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001645113-26-000062
Line itemJune 30,2026December 31,2025
United States$66,036$65,669
Switzerland46,06848,125
Israel12,99914,059
Others20,63719,146
Total long lived assets$145,740$146,999

Item 1. Financial Statements

FAQ

What is NovoCure's switzerland — total long lived assets?
NovoCure (NVCR) reported switzerland — total long lived assets of $46.07M in Q2 2026.
How has NovoCure's switzerland — total long lived assets changed year-over-year?
NovoCure's switzerland — total long lived assets increased by 208.7% year-over-year, from $14.92M to $46.07M.
What is the long-term trend for NovoCure's switzerland — total long lived assets?
Over 4 years (2021 to 2025), NovoCure's switzerland — total long lived assets has grown at a 69.7% compound annual growth rate (CAGR), from $15.44M to $127.92M.
What does switzerland — total long lived assets mean?
This metric represents the total carrying value of non-current, tangible, and intangible assets physically located or legally domiciled within the Switzerland geographic segment. It reflects the company's investment in regional infrastructure, such as manufacturing facilities, research centers, or administrative headquarters, supporting its global operations. Monitoring this balance helps investors assess the geographic concentration of capital expenditures and the operational footprint within this specific jurisdiction.

Ask your AI about NovoCure's switzerland — total long lived assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude